Giulia Kennedy

Giulia Kennedy currently serves as a Board Member at Encodia and Acuamark Diagnostics, Inc., and is the Co-Founder and Chief Scientific Officer of PinkDx, Inc. With extensive experience in the biomedical field, Kennedy has held significant positions, including Chief Scientific Officer and Chief Medical Officer at Veracyte, Inc., where contributions included leading R&D teams to generate substantial revenue and developing commercial diagnostic products. Kennedy's background also includes roles at Affymetrix, Chiron Corporation, and Millennium Pharmaceuticals, focusing on cancer gene discovery, assay development, and genetic mapping for diabetes research. Academically, Kennedy completed a Postdoctoral Fellowship in Genome Sciences at the University of California, San Francisco, and earned a Ph.D. in Biochemistry from Case Western Reserve University School of Medicine.